Needham & Company Reiterates a Buy Rating as GenMark Diagnostics (GNMK) Reports 4Q Results Consistent with Preannouncement

Go back to Needham & Company Reiterates a Buy Rating as GenMark Diagnostics (GNMK) Reports 4Q Results Consistent with Preannouncement

GenMark Diagnostics (GNMK) Tops Q4 EPS by 6c

February 23, 2016 4:42 PM EST

GenMark Diagnostics (NASDAQ: GNMK) reported Q4 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $12.3 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

... More

Trading Radar for 2/23: Home Depot (HD), Macy's (M), Ecolab (ECL), Toll Brothers (TOL), First Solar (FSLR) Report

February 22, 2016 3:20 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
9:00am EST

Case-Shiller 20-City Index - Street sees 5.8%

Earnings:

AAC Holdings (NYSE: AAC) - consensus EPS $0.18
AIXTRON SE (Nasdaq: AIXG) - consensus loss $0.01
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.60
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.31
AerCap Holdings (NYSE: AER) -... More